2m 2m 2m 2m 2m 2m 2m
ORUKA THERA (ORKA)
NASDAQ
$79.71-$4.67 (-5.54%)
Price as of Oct 06, 2026 1:56 PM EDT- $5.6BMarket Cap
- 315.05%1-Year Change
- BiotechnologyIndustry
ORUKA THERA (ORKA)
$79.71-$4.67 (-5.54%)
ORKA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $84.38 | ||
Change | -$0.14 (-0.17%) | ||
Open | $84.52 | ||
High | $85.22 | ||
Low | $81.83 | ||
Previous Close | $84.52 | ||
Volume | 629,592 | ||
30-Day Average Volume | 999,507 | ||
1-Week Change | 0.23% | ||
1-Month Change | -8.79% | ||
1-Year Change | 315.05% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 66.2M | ||
Total Assets | $1.1B | ||
Market Cap | $5.6B | ||
Enterprise Value | $5.3B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$41.2M | ||
Free Cash Flow | -$33.1M | ||
EBIT | -$41.2M | ||
EBITDA | -$41.2M | ||
Net Working Capital | $861.6M | ||
EPS | -$0.55 | ||
Enterprise Value/EBITDA | -129 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -153 | ||
PEG | 11 | ||
Price/Free Cash Flow | -169 | ||
Price/Operating Cash Flow | -169 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue